0
0
Read Time:7 Minute, 12 Second
The Digital Therapeutics Market is projected to reach $42.98 billion by 2030, at a CAGR of 31.1% from 2023 to 2030. Digital therapeutics are the software interventions used in the prevention, treatment, and management of chronic diseases, such as diabetes, prediabetes, hypertension, mental health issues, and others. Along with the connected devices, DTx mobile applications help continuously monitor healthcare parameters, such as blood glucose, A1C levels, hypertension, and oxygen, among others. The rising prevalence of chronic diseases, growing focus on preventive healthcare, and increasing shortage of healthcare professionals are driving the growth of this market.
Here are the top 10 companies operating in the Digital Therapeutics Market
Founded in 1989 and headquartered in California, U.S., ResMed Inc. is involved in developing, producing, distributing, and marketing cloud-connected medical devices and digital health. The company also offers an out-of-hospital software platform for healthcare providers. The company operates through two operating segments, Sleep and Respiratory Care and Software-as-a-Service (SaaS). The company offers products for consumers with chronic obstructive pulmonary disease (COPD), sleep apnea, and other chronic conditions through the Sleep and Respiratory Care segment.
ResMed has a presence in more than 140 countries, including the U.S., Canada, Australia, India, China, Poland, Norway, Switzerland, Taiwan, and Sweden, among others. The company distributes the products through a network of wholly-owned subsidiaries and independent distributors. The company’s manufacturing facilities are located in China, Johor Bahru, Malaysia; Tuas, Singapore; Sydney, Australia; Chatsworth, California; Atlanta, Georgia and Suzhou
Teladoc Health, Inc. (U.S.)
Founded in 2002 and headquartered in Texas, U.S., Teladoc Health, Inc., is a telemedicine and virtual healthcare company that offers healthcare experiences with better convenience, outcomes, and values. The company offers solutions globally by providing whole-person virtual care, including primary care, mental health, chronic condition management, and others.
In 2022, the company adopted a new organizational and reporting structure based on two operating segments: Teladoc Health Integrated Care and BetterHelp. The company operates in the digital therapeutics market through both segments. The company has offices and subsidiaries in Malaysia, Georgia, India, France, Chile, England, Florida, Belarus, Australia, Canada, Germany, Spain, and China. Some of its subsidiaries include BetterHelp (U.S.), Livongo Health, Inc. (U.S.), InTouch Health (U.S.), and HealthiestYou, Inc. (U.S.)
Founded in 2008 and headquartered in New York, U.S., Noom, Inc. is a healthcare software company. The company offers a digital health platform for consumers to meet their wellness and health goals, such as weight management, stress reduction, and diabetes prevention. This platform provides three solutions, Diabetes Prevention Program, Noom Mood, and Noom Weight. The company also offers a tool for personality tests and calculating micronutrients and calories.
Noom has a research team covering different areas of health, including diabetes prevention, oncology, diabetes management, hypertension, and others. The company has about 40 peer-reviewed scientific articles to inform users about how the products work and the effectiveness of the products. The company sells its products to end-users, including individuals, employers, consultants & brokers.
Biofourmis Inc. (U.S.)
Founded in 2015 and headquartered in Massachusetts, U.S., Biofourmis Inc. is involved in designing and developing digital health platforms and providing a software solution for disease management. The company operates through two segments, namely, Care Delivery and Life Science. The company offers digital therapeutic products, such as hospital-at-home, transitional care, and digital disease management solutions, through the Care Delivery segment.
The company offers configurable, connected, personalized care options for in-person and virtual patient management. Its platform uses artificial intelligence, wearables, and analytics for patient monitoring. The company’s subsidiaries are Biofourmis Singapore Pte. Ltd. (Singapore) and Gaido Health (India).
Founded in 2011 and headquartered in New York, U.S., DarioHealth Corp. is involved in designing and developing healthcare software solutions. The company offers products in the Digital Therapeutics-as-a-Service (DTaaS) category and provides digital therapeutics solutions for treating diabetes, clinical trials, hypertension, blood sugar monitoring, weight management, behavioral health, and musculoskeletal conditions. The company operates through two segments, Services and Hardware and Consumable Products. The Services segment includes software applications, and the Hardware and Consumable Products segment includes integrated devices for real-time monitoring.
The company has a presence in Canada, the U.S., Australia, India, New Zealand, Italy, the Netherlands, Germany, Israel, and the U.K. Some of its subsidiaries are LabStyle Innovation Ltd.(Israel), DarioHealth India Services Pvt. Ltd.(India), and PsyInnovations Inc.(U.S.)
Meticulous Research in its latest publication on Digital Therapeutics Market has predicted the growth of 31.1% during the forecast year 2023-2030
Virta Health Corp. (U.S.)
Founded in 2014 and headquartered in Colorado, U.S., Virta Health Corp. is a fully virtual medical clinic that has been proven to help reverse diabetes and prediabetes, help with weight loss, and improve other chronic conditions. The application that the company provides has been known to be able to lower blood sugar and A1c, reduce diabetes medications, and help to lose weight using food as a medicine.
The company offers diabetes treatment with continuous remote medical care and individualized nutrition therapy. The company offers treatment for obesity, diabetes management, prediabetes reversal, and diabetes reversal. Virta Health has presence in Denver and San Francisco.
Founded in 1997 and headquartered in Hamburg, Germany, GAIA AG is involved in developing clinically approved digital therapeutics products. The company operates through two segments, namely Digital Therapeutics and Integrated Care. The company offers over 70 CE-marked medical devices through the Digital Therapeutics segment.
The company distributes its products to end users, including patients, physicians, therapists, and payers. The company’s research & development projects cover a range of technological, medical and psychological topics, including multiple sclerosis, depression treatment, sensor technology, and major anxiety disorder. GAIA Inc. has contracts with pharmaceutical companies and payer organizations to implement digital therapy projects.
Welldoc, Inc. (U.S.)
Founded in 2005 and headquartered in Maryland, U.S., Welldoc, Inc. develops a chronic disease management platform that uses artificial intelligence to provide real-time and useful information to patients and healthcare practitioners. The platform is used to manage multiple chronic conditions, including heart failure, integrated behavioral health, type one & two diabetes, hypertension, prediabetes, and other conditions.
Welldoc, Inc. offers the platform to the end-users, such as health systems, employers, and partners. The company has over 65 clinical publications, 38 patents, over 400 connected devices and nine 510(K) FDA clearances for BlueStar.
Founded in 2011 and headquartered in California, U.S., BigHealth provides behavioral programs and fully automated, highly customized digital treatments for mental health concerns through its digital healthcare platform. The company collaborates with medical experts through its portal and provides a sleep improvement program and online individualized medical care for treating sleep-related disorders.
BigHealth has more than 74 peer-reviewed publications, over 14 randomized controlled trials (RCTs), and four clinical guidance citations. The company has a presence in San Francisco and the U.K. It has partnered with National Health Services in Scotland to offer its products to all the citizens in Scotland.
Glooko, Inc (U.S.)
Founded in 2010 and headquartered in Palo Alto, California, U.S., Glooko, Inc. is engaged in improving the health outcomes of people suffering from chronic conditions through its personalized, intelligent, connected care platform.
The company offers products in two categories, provider products and research products. Provider products consist of in-clinic and remote patient management platforms. The technologies provided by the company transform the connection between patients and providers and drive patient engagement and adherence via digital therapeutics. The company specializes in diabetes remote patient monitoring using digital therapeutics.
Glooko is globally deployed in over 30 countries and 8,000+ clinical locations. The company is HIPAA compliant, GDPR compliant, ISO 13485 compliant, and 21 CFR Part 11 compliant, and it has more than 200 devices supported and over 100 billion health data points. Its subsidiary GlookoXT, France, operates in the digital therapeutics market.
Popular Mentions – 2Morrow Inc. (U.S.), Canary Health (U.S.), Limbix Health, Inc. (U.S.), Kaia Healthcare Software, Inc. (U.S.), and others
Authoritative Research on the Digital Therapeutics Market – Global Opportunity Analysis and Industry Forecast (2023-2030)
Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following:
- Recent financial performance
- Key products
- Significant company strategies
- Partnerships and acquisitions
The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
